BFC Planning’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
BFC Planning's XPH Position: Q3 2026 in Review
BFC Planning increased its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 77% in Q3 2026, buying an estimated $25.9K and bringing the position to 864 shares worth $56.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1493.
BFC Planning first reported a position in XPH in Q3 2025 and has held it in 5 quarters since. 101 funds tracked by Wall St. Rank hold XPH as of Q3 2026.
- BFC Planning held 864 shares of State Street SPDR S&P Pharmaceuticals ETF worth $56.2K as of Q3 2026.
- BFC Planning bought 375 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2026, an estimated $25.9K.
- State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #1493 holding.
- BFC Planning first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2025 and has held it in 5 quarters since.
- 101 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.